Genomic landscape of colorectal mucosa and adenomas

Cancer Prevention Research

Volumn 9, Issue 6, 2016, Pages 417-427

  Borras, Ester ^a   Lucas, F Anthony San ^a,b   Chang, Kyle ^a,b   Zhou, Ruoji ^a,b   Masand, Gita ^a   Fowler, Jerry ^a   Mork, Maureen E ^a   You, Y Nancy ^a   Taggart, Melissa W ^a   McAllister, Florencia ^a,b   Jones, David A ^c   Davies, Gareth E ^d   Edelmann, Winfried ^e   Ehli, Erik A ^d   Lynch, Patrick M ^a   Hawk, Ernest T ^a   Capella, Gabriel ^f   Scheet, Paul ^a,b   Vilar, Eduardo ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Immunobiol Cancer Prog Oklahoma M   (United States)

^d Avera Health   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; FBXW7 PROTEIN; K RAS PROTEIN; PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG;

ADULT; ALLELIC IMBALANCE; ARTICLE; CARCINOGENESIS; CHROMOSOME 13; CHROMOSOME 5; CHROMOSOME 7; CLINICAL ARTICLE; CLONAL VARIATION; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; COPY NUMBER VARIATION; EXOME; FAMILIAL COLON POLYPOSIS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; GENOMICS; HUMAN; INTESTINE INJURY; MALE; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; WNT SIGNALING PATHWAY; ADENOMA; CELL TRANSFORMATION; COLORECTAL TUMOR; DNA MUTATIONAL ANALYSIS; GENETICS; INTESTINE MUCOSA; PATHOLOGY;

ADENOMA; ADULT; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; WNT SIGNALING PATHWAY;

EID: 84973164097     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-16-0081     Document Type: Article

References (33)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29.
2. Fearon ER.Molecular genetics of colorectal cancer. Annu Rev Pathol 2011;6:479-507.
3. Diamond SJ, Enestvedt BK, Jiang Z, Holub JL, Gupta M, Lieberman DA, et al. Adenoma detection rate increases with each decade of life after 50 years of age. Gastrointest Endosc 2011;74:135-40.
4. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW.Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58:1130-4.
5. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101:385-98.
6. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-7.
7. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7.
8. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13.
9. Tomasetti C, Vogelstein B, Parmigiani G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci U S A 2013;110:1999-2004.
10. Vattathil S, Scheet P. Haplotype-based profiling of subtle allelic imbalance with SNP arrays. Genome Res 2013;23:152-8.
11. Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB, et al. Recurrent R-spondin fusions in colon cancer. Nature 2012;488: 660-4.
12. Xie T, G DA, Lamb JR, Martin E, Wang K, Tejpar S, et al. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations. PLoS One 2012;7:e42001.
13. Dennis GJr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003;4:P3.
14. Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012;30:413-21.
15. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancerassociated genes. Nature 2013;499:214-8.
16. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature 2013; 500:415-21. 17.
17. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, et al. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A 2010;107:18545-50.
18. De Keersmaecker K, Atak ZK, Li N, Vicente C, Patchett S, Girardi T, et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet 2013;45:186-90.
19. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013;6:pl1.
20. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010;42:30-5.
21. Hirsch D, Camps J, Varma S, Kemmerling R, Stapleton M, Ried T, et al. A new whole genome amplification method for studying clonal evolution patterns in malignant colorectal polyps. Genes Chromosomes Cancer 2012;51:490-500.
22. Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, van De Wiel MA, et al. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 2009;58:79-89.
23. Mehrvarz Sarshekeh A, Overman MJ, Kee BK, Fogelman DR, Dasari A, Raghav KPS, et al. Demographic, tumor characteristics, and outcomes associated with SMAD4 mutation in colorectal cancer. J Clin Oncol 34, 2016(suppl 4S; abstr 565).
24. Tarafa G, Prat E, Risques RA, Gonzalez S, Camps J, Grau M, et al. Common genetic evolutionary pathways in familial adenomatous polyposis tumors. Cancer Res 2003;63:5731-7.
25. Albuquerque C, Breukel C, van Der Luijt R, Fidalgo P, Lage P, Slors FJ, et al. The just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 2002;11:1549-60.
26. Kohler EM, Derungs A, Daum G, Behrens J, Schneikert J. Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours. Hum Mol Genet 2008;17:1978-87.
27. Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J, et al. the type of somatic mutation at apc in familial adenomatous polyposis is determined by the site of the germline mutation: A new facet to knudson's two-hit' hypothesis. Nat Med 1999;5:1071-5.
28. Kahn M. Can we safely target the WNT pathway? Nat Rev Drug Discov 2014;13:513-32.
29. van Der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 2009;71:241-60.
30. Sottoriva A, Kang H, Ma Z, Graham TA, Salomon MP, Zhao J, et al. A Big Bang model of human colorectal tumor growth. Nat Genet 2015;47: 209-16.
31. Nishioka M, Ueno K, Hazama S, Okada T, Sakai K, Suehiro Y, et al. Possible involvement of Wnt11 in colorectal cancer progression. Mol Carcinog 2013;52:207-17.
32. Cajuso T, Hanninen UA, Kondelin J, Gylfe AE, Tanskanen T, Katainen R, et al. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A inmicrosatellite unstable colorectal cancer. Int J Cancer 2014;135:611-23.
33. Lamlum H, Papadopoulou A, Ilyas M, Rowan A, Gillet C, Hanby A, et al. APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci U S A 2000;97:2225-8.